Cargando…
The Role of the 21-Gene Recurrence Score(®) Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
The management of patients with hormone receptor-positive breast cancer has changed dramatically with use of the 21-gene Recurrence Score(®) (RS) Assay. While the utility of the assay was initially demonstrated among node-negative patients, recent studies have also demonstrated the assay’s prognosti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947241/ https://www.ncbi.nlm.nih.gov/pubmed/35323363 http://dx.doi.org/10.3390/curroncol29030163 |